Published in Gene Therapy Weekly, March 15th, 2001
"Although the B7 family is known to be the most potent of the co-stimulatory molecules, gene transduction of B7 alone has not been effective in inducing anti-tumor immunity in nonimmunogenic tumors by ex vivo methods, much less in vivo," wrote T. Todo and colleagues in Cancer Research.
The researchers used defective herpes...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.